Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-04-12

FDA Approved: AKYNZEO — Supplemental Application (Helsinn Therapeutics (U.S.), Inc.)

View source ↗

Summary

The FDA approved a supplemental application for AKYNZEO (netupitant and palonosetron) from Helsinn Therapeutics (U.S.), Inc., expanding the approved labeling fo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Akynzeo (netupitant/palonosetron)

Snippet

SUPPL AP for AKYNZEO (NETUPITANT AND PALONOSETRON)